Welcome to our dedicated page for Chicago Rivet SEC filings (Ticker: CVR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the nuts-and-bolts behind Chicago Rivet & Machine Co.’s results? Investors often start with the 10-K to gauge how steel costs and automotive demand shape margins, then move to each 10-Q quarterly earnings report for order-book trends. Our platform places every filing in one streamlined view and adds AI-powered summaries so you can breeze through 200 pages in minutes.
Use the left rail to jump straight to a Chicago Rivet & Machine insider trading Form 4 transactions feed. Real-time alerts flag when executives buy or sell—critical for a tightly held small-cap. Need context? The same page offers Chicago Rivet & Machine Form 4 insider transactions real-time charts, plus plain-English notes that explain why a sale might simply be a tax-related disposal.
If you are asking “How do I read the Chicago Rivet & Machine annual report 10-K simplified?” or “Where is the Chicago Rivet & Machine quarterly earnings report 10-Q filing?” the answer is one click away. Each document comes with key-metric callouts, trend graphs, and footnote highlights created by our AI. You can also dive into the Chicago Rivet & Machine proxy statement executive compensation section to compare director fees, or review Chicago Rivet & Machine 8-K material events explained for sudden plant shutdowns or customer wins.
Whether you’re tracking Chicago Rivet & Machine earnings report filing analysis, monitoring cash flow swings, or simply understanding Chicago Rivet & Machine SEC documents with AI, Stock Titan delivers the data and clarity you need—updated the instant EDGAR posts.
Schedule 13G Overview: The joint filing discloses that Kanen Wealth Management LLC, its managing member David L. Kanen, and two affiliated investment vehicles—Philotimo Fund LP and Philotimo Focused Growth & Income Fund (PHLOX)—collectively own 381,805 shares of AYTU BioPharma, Inc. (AYTU) common stock, representing approximately 6.2 % of the 6,170,246 shares outstanding as of 1 May 2025.
The ownership is split as follows: Philotimo Fund holds 255,810 shares (4.1 %), PHLOX holds 125,995 shares (2.0 %), while Kanen Wealth Management and Mr. Kanen are deemed to beneficially own the aggregate total by virtue of their control positions. All voting and dispositive powers are reported as shared; no individual entity has sole authority over the shares. The filing is made pursuant to Rule 13d-1(c), indicating a passive investment intent. Certifications clarify the securities were not acquired to influence or change control of the issuer.
Investor take-aways: 1) A single concentrated investment adviser has crossed the 5 % threshold, adding a noteworthy institutional holder to AYTU’s register. 2) Although passive, the group’s stake could still provide support for future capital raises or governance matters given AYTU’s relatively small float. 3) No new purchase price, cost basis, or transactional timeline beyond the 14 May 2025 “event date” is disclosed, limiting insight into buying momentum.
FAQ
What is the current stock price of Chicago Rivet (CVR)?
What is the market cap of Chicago Rivet (CVR)?
What are the primary business segments of Chicago Rivet & Machine Co?
Who are the main customers of Chicago Rivet & Machine Co?
How does Chicago Rivet & Machine Co generate revenue?
What industries does Chicago Rivet serve?
What distinguishes Chicago Rivet & Machine Co from its competitors?
How long has Chicago Rivet been in operation?
What is the role of quality control in the company’s operations?
How does Chicago Rivet integrate with the industrial supply chain?
